David P. Foley

Showing 1-5 of 5 articles

Culotte stenting for coronary bifurcation lesions with 2nd and 3rd generation everolimus-eluting stents: the CELTIC Bifurcation Study

Walsh S, Hanratty C, Watkins S, Oldroyd K, Mulvihill N, Hensey M, Chase A, Smith D, Cruden N, Spratt J, Mylotte D, Johnson T, Hill J, Hussein H, Bogaerts K, Morice M, Foley DP

June 14, 2018 | 10.4244/EIJ-D-18-00346

Interventions for stroke

Real-world safety and efficacy of WATCHMAN LAA closure at one year in patients on dual antiplatelet therapy: results of the DAPT subgroup from the EWOLUTION all-comers study

Bergmann M, Ince H, Kische S, Schmitz T, Meincke F, Schmidt B, Foley DP, Betts TR, Grygier M, Protopopov A, Stein KM, Boersma L

April 20, 2018 | 10.4244/EIJ-D-17-00672

Six-month and one-year clinical outcomes after placement of a dedicated coronary bifurcation stent: a patient-level pooled analysis of eight registry studies

Grundeken M.J, Asgedom S, Damman P, Lesiak M, Norell M, Garcia E, Bethencourt A, Woudstra P, Koch K, Vis M, Henriques J, Onuma Y, Foley DP, Bartorelli A, Stella P, Thijssen J, de Winter R, Wykrzykowska J

June 28, 2013 | 10.4244/EIJV9I2A34

Acute procedural and six-month clinical outcome in patients treated with a dedicated bifurcation stent for left main stem disease: the TRYTON LM multicentre registry

Magro M, Girasis C, Bartorelli A, Tarantini G, Russo F, Trabattoni D, D’Amico G, Galli M, Juame A, de Sousa Almeida M, Simsek C, Foley DP, Sonck J, Lesiak M, Kayaert P, Serruys P, van Geuns R

March 22, 2013 | 10.4244/EIJV8I11A194

A prospective multicentre registry, evaluating real-world usage of the Tryton side branch stent: results of the E-Tryton 150/Benelux registry

Agostoni P, Foley DP, Lesiak M, Belkacemi A, Dens J, Kumsars I, Scott B, Oemrawsingh P, Dubois C, Garcia E, Lefèvre T, Stella P

March 21, 2012 | 10.4244/EIJV7I11A204

1

Latest news

Infective Endocarditis & TAVI; Cerebral Protection Devices; IVUS Assessment in ViV-TAVI, Mini Focus on Antithrombotic Therapy …

February 19, 2021

MitraClip for a range of LV dysfunction and secondary MR

Stamatios Lerakis et al.

Thrombolysis in ST-elevation myocardial infarction is not dead

Petr Kala et al.

SCOPE 2, COACT 1 year, FORZA, COMPARE CRUSH

(Thanks to the support of Biotronik)

February 28, 2021

Guidance Papers

Guidelines, consensus & position papers

August 28, 2020

This Week's JAA's: Impact of crossing strategy on CTO recanalisation outcomes and more...

The Year in Review

M. Lunardi et al.

January 22, 2021

Valvular disease